论文部分内容阅读
经腹置管同步双相化疗栓塞术是治疗肝癌的一种新方法。临床应用５１例，经临床实践和肝储备功能的监测，作者认为该疗法具有操作简单、安全可靠、术后并发症少、疗效确切的特点。１年生存率３４／５１（６６．６％），２年生存率１６／５１（３１．３％），３例超过３年。本文简要讨论应用的基本理论，置管方法和其优点。提示该方法适合我国目前国情，是综合治疗肝癌的有效方法之一。
Trans-abdominal catheter simultaneous biphasic chemoembolization is a new method for the treatment of liver cancer. Clinical application of 51 cases, the clinical practice and liver reserve function monitoring, the author believes that the treatment is simple, safe, reliable, less postoperative complications, the exact effect of the characteristics. The 1-year survival rate was 34/51 (66.6%), the 2-year survival rate was 16/51 (31.3%), and 3 cases exceeded 3 years. This article briefly discusses the basic theory of application, the method of setting and its advantages. It suggests that this method is suitable for China’s current national conditions and is one of the effective methods for comprehensive treatment of liver cancer.